| Recruiting | To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL Peripheral T Cell Lymphoma | Phase 3 | 2023-10-04 |
| Recruiting | Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hem Advanced Solid Tumors, Hematologic Malignancies | Phase 1 | 2022-12-28 |
| Completed | This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) Atopic Dermatitis | Phase 3 | 2022-10-01 |
| Completed | A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermati Atopic Dermatitis | Phase 3 | 2022-09-15 |
| Unknown | PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Hematologic Diseases | Phase 1 | 2020-08-15 |
| Completed | Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Tri Solid Tumor, Hematological Malignancies | Phase 1 | 2019-08-05 |
| Completed | Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes Solid Tumors, Hematological Malignancies | Phase 1 | 2016-04-27 |
| Terminated | To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Imp Relapsed/Refractory Solid Tumors/Hematological Malignancies | Phase 1 | 2016-03-01 |
| Completed | A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) Peripheral T-Cell Lymphoma (PTCL) | Phase 1 | 2015-11-10 |
| Completed | Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignanc Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma | Phase 2 | 2014-07-01 |
| Completed | Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2013-09-01 |
| Completed | Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) Peripheral T-cell Lymphoma | Phase 1 | 2013-05-01 |
| Withdrawn | Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Non-Small Cell Lung Cancer | Phase 1 | 2013-04-01 |
| Withdrawn | Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folo Non Hodgkin's Lymphoma | Phase 1 | 2013-03-01 |
| Completed | Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transpl Multiple Myeloma | Phase 2 | 2012-12-01 |
| Completed | MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NS Stage IV Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2010-12-01 |
| Completed | To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory C Sarcoma, Neuroblastoma, Wilms Tumor | Phase 1 | 2010-09-01 |
| Completed | Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma, Mycosis Fungoides, Sezary Syndrome | Phase 1 | 2010-03-01 |
| Completed | Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer Breast Cancer, Breast Tumors, Neoplasms, Breast | Phase 2 | 2010-03-01 |
| Completed | Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry Peripheral T-cell Lymphoma | — | 2010-02-01 |
| Completed | PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantat Multiple Myeloma | Phase 2 | 2010-01-01 |
| Completed | Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Blad Carcinoma, Transitional Cell, Bladder Cancer, Bladder Neoplasm | Phase 2 | 2008-07-01 |
| Completed | Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma | Phase 1 | 2007-08-01 |
| Completed | Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Mal Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma | Phase 1 / Phase 2 | 2007-05-01 |
| Completed | Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cel Peripheral T-cell Lymphoma | Phase 2 | 2006-08-01 |
| Completed | Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction Malignant Melanoma | Phase 1 | 2005-02-01 |
| Completed | Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2002-07-01 |
| Completed | Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma | Phase 1 / Phase 2 | 2001-09-01 |